New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
06:59 EDTDVAXDynavax initiated with a Neutral at JPMorgan
JPMorgan cites regulatory risks associated with HEPLISAV for its Neutral rating on Dynavax.
News For DVAX From The Last 14 Days
Check below for free stories on DVAX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for DVAX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use